AI-Designed vaccine takes on colorectal cancer in new trial
NCT ID NCT07328087
First seen Jan 11, 2026 · Last updated May 21, 2026 · Updated 18 times
Summary
This early-phase trial tests a personalized cancer vaccine made using AI and quantum physics, given alongside standard chemotherapy and an immunotherapy drug. It is for people with stage III colorectal cancer that has been completely removed by surgery. The main goal is to see if the combination is safe and tolerable for 12 participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER METASTATIC are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Biogenea Pharmaeuticals Ltd
RECRUITINGThessaloniki, 54627, Greece
Conditions
Explore the condition pages connected to this study.